Dashboard
Manage Tickers

VRTX VERTEX PHARMACEUTICALS INC ...

Nasdaq vrtx.com


$ 421.36 $ 11.73 (2.86 %)    

Monday, 10-Nov-2025 16:37:15 EST
CLICK TO SEE RELEVANT LITIGATION UPDATES
QQQ $ 623.82 $ 4.38 (0.71 %)
DIA $ 473.95 $ 1.94 (0.41 %)
SPY $ 681.69 $ 4.15 (0.61 %)
TLT $ 89.46 $ 0.06 (0.07 %)
GLD $ 380.15 $ 2.40 (0.64 %)
$ 421.2
$ 412.38
$ 406.00 x 10
$ 424.00 x 5
$ 410.50 - $ 422.23
$ 362.50 - $ 519.68
1,494,401
na
106.87B
$ 0.54
$ 29.08
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 11-04-2025 09-30-2025 10-Q
2 08-05-2025 06-30-2025 10-Q
3 05-06-2025 03-31-2025 10-Q
4 02-13-2025 12-31-2024 10-K
5 11-05-2024 09-30-2024 10-Q
6 08-02-2024 06-30-2024 10-Q
7 05-07-2024 03-31-2024 10-Q
8 02-15-2024 12-31-2023 10-K
9 11-07-2023 09-30-2023 10-Q
10 08-02-2023 06-30-2023 10-Q
11 05-02-2023 03-31-2023 10-Q
12 02-10-2023 12-31-2022 10-K
13 10-28-2022 09-30-2022 10-Q
14 08-05-2022 06-30-2022 10-Q
15 05-06-2022 03-31-2022 10-Q
16 02-09-2022 12-31-2021 10-K
17 11-03-2021 09-30-2021 10-Q
18 07-30-2021 06-30-2021 10-Q
19 04-30-2021 03-31-2021 10-Q
20 02-11-2021 12-31-2020 10-K
21 10-30-2020 09-30-2020 10-Q
22 07-31-2020 06-30-2020 10-Q
23 05-01-2020 03-31-2020 10-Q
24 02-13-2020 12-31-2019 10-K
25 10-31-2019 09-30-2019 10-Q
26 08-01-2019 06-30-2019 10-Q
27 05-01-2019 03-31-2019 10-Q
28 02-13-2019 12-31-2018 10-K
29 10-25-2018 09-30-2018 10-Q
30 07-26-2018 06-30-2018 10-Q
31 04-27-2018 03-31-2018 10-Q
32 02-15-2018 12-31-2017 10-K
33 10-30-2017 09-30-2017 10-Q
34 07-28-2017 06-30-2017 10-Q
35 04-28-2017 03-31-2017 10-Q
36 02-23-2017 12-31-2016 10-K
37 10-31-2016 09-30-2016 10-Q
38 08-01-2016 06-30-2016 10-Q
39 05-03-2016 03-31-2016 10-Q
40 02-16-2016 12-31-2015 10-K
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

reported-saturday-vertex-48-week-ruby-3-data-show-64-proteinuria-decrease-in-iga-nephropathy-and-82-decrease-in-primary-membranous-nephropathy-with-egfr-stabilization
Reported Saturday, Vertex 48-Week RUBY-3 D...
11/10/2025 08:49:03

- 48-week data show a 64% decrease from baseline in proteinuria in IgA nephropathy, 82% decrease from baseline in proteinuria i...

ubs-maintains-buy-on-vertex-pharmaceuticals-lowers-price-target-to-546
UBS Maintains Buy on Vertex Pharmaceutical...
11/07/2025 18:23:35

UBS analyst Colin Bristow maintains Vertex Pharmaceuticals (NASDAQ:VRTX) with a Buy and lowers the price target from $553 to...

fda-fast-tracks-6-more-drugs---obesity-and-cancer-drugs-included
FDA Fast-Tracks 6 More Drugs - Obesity And...
11/07/2025 14:54:21

FDA adds six drugs to its priority voucher program as CMS and the White House unveil measures to speed reviews and lower prescr...

palantir-weighs-on-wall-street-bitcoin-slumps-5-whats-moving-markets-tuesday
Palantir Weighs On Wall Street, Bitcoin Sl...
11/04/2025 18:22:32

Risk appetite cooled on Tuesday as investors interpreted the latest batch of corporate earnings as solid but not spectacular, o...

rbc-capital-maintains-sector-perform-on-vertex-pharmaceuticals-lowers-price-target-to-415
RBC Capital Maintains Sector Perform on Ve...
11/04/2025 16:45:55

RBC Capital analyst Brian Abrahams maintains Vertex Pharmaceuticals (NASDAQ:VRTX) with a Sector Perform and lowers the price...

barclays-maintains-equal-weight-on-vertex-pharmaceuticals-raises-price-target-to-414
Barclays Maintains Equal-Weight on Vertex ...
11/04/2025 14:27:04

Barclays analyst Gena Wang maintains Vertex Pharmaceuticals (NASDAQ:VRTX) with a Equal-Weight and raises the price target fr...

stifel-maintains-hold-on-vertex-pharmaceuticals-lowers-price-target-to-445
Stifel Maintains Hold on Vertex Pharmaceut...
11/04/2025 12:41:47

Stifel analyst Paul Matteis maintains Vertex Pharmaceuticals (NASDAQ:VRTX) with a Hold and lowers the price target from $455...

vertex-pharmaceuticals-raises-fy2025-sales-guidance-from-11850b-12000b-to-11900b-12000b-vs-11987b-est
Vertex Pharmaceuticals Raises FY2025 Sales...
11/03/2025 21:49:25

Vertex Pharmaceuticals (NASDAQ:VRTX) raises FY2025 sales outlook from $11.850 billion-$12.000 billion to $11.900 billion-$12.00...

vertex-pharmaceuticals-q3-adj-eps-480-beats-456-estimate-sales-3076b-beat-3053b-estimate
Vertex Pharmaceuticals Q3 Adj. EPS $4.80 B...
11/03/2025 21:48:36

Vertex Pharmaceuticals (NASDAQ:VRTX) reported quarterly earnings of $4.80 per share which beat the analyst consensus estimate o...

vertex-pharmaceuticals-likely-to-report-higher-q3-earnings-these-most-accurate-analysts-revise-forecasts-ahead-of-earnings-call
Vertex Pharmaceuticals Likely To Report Hi...
11/03/2025 19:23:32

nvidia-amazon-extend-rally-bitcoin-sinks-to-107000-whats-moving-markets-monday
Nvidia, Amazon Extend Rally, Bitcoin Sinks...
11/03/2025 18:01:11

Wall Street opened the week on a mixed note on Monday.

earnings-scheduled-for-november-3-2025
Earnings Scheduled For November 3, 2025
11/03/2025 11:11:31

preview-vertex-pharmaceuticalss-earnings
Preview: Vertex Pharmaceuticals's Earnings
10/31/2025 14:01:31

heres-how-much-100-invested-in-vertex-pharmaceuticals-15-years-ago-would-be-worth-today
Here's How Much $100 Invested In Vertex Ph...
10/30/2025 23:00:35

vertex-pharmaceuticals-presents-multiple-abstracts-showing-clinical-benefits-of-cftr-modulators-at-north-american-cystic-fibrosis-conference-in-seattle
Vertex Pharmaceuticals Presents Multiple A...
10/23/2025 13:06:38

Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced the presentation of multiple abstracts demonstrating the cli...

reported-earlier-vertex-advances-povetacicept-program-with-fda-rolling-review-for-igan-initiates-olympus-a-phase-2b3-pivotal-study-of-pove-for-the-treatment-of-pmn-and-announces-updated-date-from-ruby-3-trial-accepted-for-late-breaking-american-society-of-nephrology-2025-presentation
Reported Earlier: Vertex Advances Povetaci...
10/17/2025 15:34:58

- Food and Drug Administration grants rolling review of Biologics License Application for povetacicept in IgA nephropathy; Vert...

vera-therapeutics-lead-kidney-drug-poised-for-2026-launch-in-multi-billion-dollar-market
Vera Therapeutics' Lead Kidney Drug Poised...
10/16/2025 18:17:37

Bank of America initiates coverage on Vera Therapeutics, citing strong potential for atacicept, its kidney treatment.

heres-how-much-100-invested-in-vertex-pharmaceuticals-10-years-ago-would-be-worth-today
Here's How Much $100 Invested In Vertex Ph...
10/14/2025 14:15:20

morgan-stanley-maintains-equal-weight-on-vertex-pharmaceuticals-lowers-price-target-to-438
Morgan Stanley Maintains Equal-Weight on V...
10/10/2025 17:32:10

Morgan Stanley analyst Terence Flynn maintains Vertex Pharmaceuticals (NASDAQ:VRTX) with a Equal-Weight and lowers the price...

spotlight-on-vertex-pharmaceuticals-analyzing-the-surge-in-options-activity
Spotlight on Vertex Pharmaceuticals: Analy...
10/08/2025 18:01:11

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION